The Danish Bladder Cancer Group 23 Study - A Nordic Study on Cancer in the Upper Urinary Tract

Not yet recruitingOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2030

Study Completion Date

June 30, 2040

Conditions
Upper Urinary Tract Urothelial Carcinoma
Interventions
PROCEDURE

Kidney sparing surgery for high-risk upper urinary tract urothelial carcinoma

"This is an observational cohort study with no direct intervention assigned by the investigators. The study compares two groups of patients in our cohort diagnosed with high-risk pTa upper tract urothelial carcinoma (UTUC), as defined by the European Association of Urology (EAU) guidelines. The experimental group includes patients who, due to imperative indications (e.g., solitary kidney, impaired renal function, or comorbidities), undergo kidney-sparing surgery. These patients are compared to a reference group treated with radical nephroureterectomy, which is considered standard of care."

Trial Locations (3)

2100

Department of Urology, Copenhagen University Hospital - Rigshospitalet, København Ø

2730

Herlev Gentofte Hospital, Herlev

4000

Department of Urology, Zealand University Hospital, Roskilde

All Listed Sponsors
collaborator

Aarhus University Hospital Skejby

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Copenhagen University Hospital at Herlev

OTHER

lead

Zealand University Hospital

OTHER

NCT07077447 - The Danish Bladder Cancer Group 23 Study - A Nordic Study on Cancer in the Upper Urinary Tract | Biotech Hunter | Biotech Hunter